Form 4: Arvinas Director Receives Stock Options and RSUs

Arvinas, Inc. Director Everett Cunningham was granted stock options and restricted stock units on June 24, 2026, with vesting conditions tied to continued service.

Summary

• Director Everett Cunningham of Arvinas, Inc. received a grant of 15,527 shares of Common Stock on June 24, 2026.
• Additionally, Cunningham was granted stock options to purchase 22,714 shares of Common Stock at an exercise price of $8.05 per share.
• The restricted stock units (RSUs) vest in full on the earlier of June 24, 2027, or immediately prior to the first annual meeting of stockholders after the grant date, contingent upon continued service.
• The stock option award also vests in full on the earlier of June 24, 2027, or immediately prior to the first annual meeting of stockholders after the grant date, subject to continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents standard compensation for a director and does not indicate significant new developments or changes in the company's financial performance.

Positives

• Director Everett Cunningham received equity awards, indicating continued investment and alignment with the company's performance.
• The grant of stock options and RSUs suggests management's confidence in future stock appreciation.
• Vesting conditions tied to continued service incentivize long-term commitment from the director.

Risks

• The value of the stock options and RSUs is subject to market fluctuations and the company's future performance.
• Vesting is contingent on continued service, meaning forfeiture is possible if the director leaves the company before the vesting date.

Future Outlook

The vesting conditions for both the RSUs and stock options are tied to continued service and a specific date or the first annual meeting of stockholders, indicating a forward-looking incentive structure.

Industry Context

StockSavvy.ai notes that the issuance of stock options and RSUs to directors is a common practice in the biotechnology and pharmaceutical sectors, aligning executive and director interests with shareholder value creation through long-term performance incentives.

Stakeholder Impact

• Shareholders: The issuance of equity awards to directors aligns their interests with shareholders, potentially leading to decisions that enhance shareholder value.
• Employees: While not directly impacting employees, such grants can reflect a broader compensation philosophy within the company.
• Management: The grants reinforce the director's commitment and provide a financial incentive tied to the company's success.

Next Steps

• Director Everett Cunningham is expected to continue his service with Arvinas, Inc. for the RSUs and stock options to vest.
• The RSUs and stock options will vest on the earlier of June 24, 2027, or immediately prior to the first annual meeting of stockholders after the grant date.

Key Dates

Keywords

Arvinas, ARVN, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director Compensation, SEC Filing, Equity Awards